These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 1363986)
1. [Sulfasalazine in the treatment of rheumatoid arthritis. A multicenter open study of 150 patients during 6 months]. Rev Rhum Mal Osteoartic; 1992 Nov; 59(11):707-13. PubMed ID: 1363986 [TBL] [Abstract][Full Text] [Related]
3. [Therapeutic maintenance and tolerance of sulfasalazine in rheumatoid polyarthritis. Retrospective study of 95 patients]. Pertuiset E; Lioté F; Chevret S; Bardin T; Dryll A; Kuntz D Rev Rhum Mal Osteoartic; 1992 Oct; 59(9):545-52. PubMed ID: 1363000 [TBL] [Abstract][Full Text] [Related]
4. Sulfasalazine in severe rheumatoid arthritis: a study to assess potential correlates of efficacy and toxicity. Martin L; Sitar DS; Chalmers IM; Hunter T J Rheumatol; 1985 Apr; 12(2):270-3. PubMed ID: 2863375 [TBL] [Abstract][Full Text] [Related]
6. Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group. Kalden JR; Scott DL; Smolen JS; Schattenkirchner M; Rozman B; Williams BD; Kvien TK; Jones P; Williams RB; Oed C; Rosenburg R; J Rheumatol; 2001 Sep; 28(9):1983-91. PubMed ID: 11550964 [TBL] [Abstract][Full Text] [Related]
7. Response to sulfasalazine in rheumatoid arthritis: life table analysis of a 5-year followup. Jones E; Jones JV; Woodbury JF J Rheumatol; 1991 Feb; 18(2):195-8. PubMed ID: 1673722 [TBL] [Abstract][Full Text] [Related]
8. When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide? Dougados M; Emery P; Lemmel EM; Zerbini CA; Brin S; van Riel P Ann Rheum Dis; 2005 Jan; 64(1):44-51. PubMed ID: 15271770 [TBL] [Abstract][Full Text] [Related]
10. A one-year, open, prospective study of sulfasalazine in the treatment of rheumatoid arthritis: adverse reactions and clinical response in relation to laboratory variables, drug and metabolite serum levels, and acetylator status. Chalmers IM; Sitar DS; Hunter T J Rheumatol; 1990 Jun; 17(6):764-70. PubMed ID: 1974926 [TBL] [Abstract][Full Text] [Related]
11. Long-term usage and side-effect profile of sulphasalazine in rheumatoid arthritis. van Riel PL; van Gestel AM; van de Putte LB Br J Rheumatol; 1995 Nov; 34 Suppl 2():40-2. PubMed ID: 8535648 [TBL] [Abstract][Full Text] [Related]
12. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739 [TBL] [Abstract][Full Text] [Related]
13. The use of the AIMS questionnaire in the evaluation of sulphasalazine treatment in rheumatoid arthritis. Pelísková Z; Trnavský K; Vácha J Z Rheumatol; 1987; 46(3):124-8. PubMed ID: 2442919 [TBL] [Abstract][Full Text] [Related]
15. Sulphasalazine in the treatment of rheumatoid arthritis. Pelísková Z; Vácha J; Trnavský K Z Rheumatol; 1985; 44(6):263-6. PubMed ID: 2869625 [TBL] [Abstract][Full Text] [Related]
16. Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis. Shergy WJ; Isern RA; Cooley DA; Harshbarger JL; Huffstutter JE; Hughes GM; Spencer-Smith EA; Goldman AL; Roth SH; Toder JS; Warner D; Quinn A; Keenan GF; Schaible TF; J Rheumatol; 2002 Apr; 29(4):667-77. PubMed ID: 11950005 [TBL] [Abstract][Full Text] [Related]
17. [Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis]. Mundo A; Pedone V; Lamanna G; Cervini C Clin Ter; 1997; 148(1-2):7-13. PubMed ID: 9377840 [TBL] [Abstract][Full Text] [Related]
18. Sulfasalazine has a better efficacy/toxicity profile than auranofin--evidence from a 5 year prospective, randomized trial. McEntegart A; Porter D; Capell HA; Thomson EA J Rheumatol; 1996 Nov; 23(11):1887-90. PubMed ID: 8923361 [TBL] [Abstract][Full Text] [Related]
19. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies. Saunders SA; Capell HA; Stirling A; Vallance R; Kincaid W; McMahon AD; Porter DR Arthritis Rheum; 2008 May; 58(5):1310-7. PubMed ID: 18438851 [TBL] [Abstract][Full Text] [Related]
20. Etanercept in combination with sulfasalazine, hydroxychloroquine, or gold in the treatment of rheumatoid arthritis. O'Dell JR; Petersen K; Leff R; Palmer W; Schned E; Blakely K; Haire C; Fernandez A J Rheumatol; 2006 Feb; 33(2):213-8. PubMed ID: 16358366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]